| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/14/2005 | US20050080000 Anion/cationic exchanging and chromatography; crystallization |
| 04/14/2005 | US20050079619 Using wreck and check molecular genetics as tool to identify gene sequences associated with virulence, pathogenicity and essential functioning of diploid pathogenic fungi; finding targets for antifungal agent discovery |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079596 Nitrite-oxidizing bacteria and methods of using and detecting the same |
| 04/14/2005 | US20050079593 Modified enzymes having polymer conjugates |
| 04/14/2005 | US20050079585 Complement depletion using recombinant human C3-derivatives |
| 04/14/2005 | US20050079584 Modified factor VIII |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079580 Novel human proteins and polynucleotides encoding the same |
| 04/14/2005 | US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease |
| 04/14/2005 | US20050079577 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/14/2005 | US20050079576 Binding polypeptide, for use in the detection and treatment of prostate cancer |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079573 Proteins |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079571 Phosphate limited inducible promoter and a bacillus expression system |
| 04/14/2005 | US20050079553 SSX-2 peptides presented by HLA class II molecules |
| 04/14/2005 | US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors |
| 04/14/2005 | US20050079549 Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same |
| 04/14/2005 | US20050079547 Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy |
| 04/14/2005 | US20050079546 Serum albumin scaffold-based proteins and uses thereof |
| 04/14/2005 | US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/14/2005 | US20050079539 Novel gene encoding brain specific membrane protein |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079522 Novel human protocadherin proteins and polynucleotides encoding the same |
| 04/14/2005 | US20050079515 Compositions, splice variants and methods relating to breast specific nucleic acids and proteins |
| 04/14/2005 | US20050079503 Peptide comprising zinc binding of ubiquination protein for use as tool in identifying modulators for treatment and prevention of inflammation, reproductive and cell proliferation disorders |
| 04/14/2005 | US20050079498 Expression vector comprising nucleotide sequences coding polypeptide associated with clavam compounds for use in transformation and generation of cells with improved clavulanic acid production |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079183 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 04/14/2005 | US20050079182 Immunogenic compositions of human papillomavirus and sera produced therefrom |
| 04/14/2005 | US20050079180 Manipulatin of oocyte maturation and male germ cell survival |
| 04/14/2005 | US20050079175 Administering receptor ligand protein suspension to prevent binding to lymphocytes |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079171 Inducing immunology response; administering to mucous membranes |
| 04/14/2005 | US20050079168 Virulence genes proteins and their use |
| 04/14/2005 | US20050079163 Administering retroviral vector containing nucleic acid encoding a gene; antiproliferative agents; antitumor agents |
| 04/14/2005 | US20050079160 polynucleotides, small interfering RNA or genetic vectors that inhibit expression of genes that code for osmosis stress resistance proteins, used as nematocides |
| 04/14/2005 | US20050079154 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities |
| 04/14/2005 | DE10344799A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 04/14/2005 | DE10344545A1 New isolated, truncated capsid protein C1 of beak and feather disease virus, useful in vaccines and as a diagnostic agent, and its encoding nucleic acid |
| 04/14/2005 | CA2814613A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2545639A1 Regulation of matrix metalloproteinases by psp94 family members |
| 04/14/2005 | CA2542004A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/14/2005 | CA2542002A1 Methods for modulating neuronal responses using inhibitors of ampa receptor endocytosis |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541015A1 Igf binding proteins |
| 04/14/2005 | CA2541006A1 Tim-3 polypeptides |
| 04/14/2005 | CA2540890A1 Treatment of demyelinating autoimmune disease with modified ordered peptides |
| 04/14/2005 | CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | CA2540837A1 Mammalian t1r3 sweet taste receptors |
| 04/14/2005 | CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | CA2540665A1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/14/2005 | CA2540622A1 Transgenic animals with serious disorders related to alzheimer's disease |
| 04/14/2005 | CA2540348A1 Methods for enhancing stress tolerance in plants and methods thereof |
| 04/14/2005 | CA2540275A1 Novel splice variants of human dkkl1 |
| 04/14/2005 | CA2539440A1 Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions |
| 04/14/2005 | CA2537793A1 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 04/14/2005 | CA2537326A1 C1q related protein |
| 04/14/2005 | CA2532369A1 Immunogenic compositions for streptococcus pyogenes |
| 04/14/2005 | CA2526841A1 Novel calcium channels and uses thereof |
| 04/14/2005 | CA2526425A1 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof |
| 04/14/2005 | CA2524209A1 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 04/13/2005 | EP1522856A1 Method for the detection of a neurological or psychiatric, demential disease, especially Alzheimer's disease by use of cholecystokinin (CCK)-molecules, corresponding substances and detection reagents |
| 04/13/2005 | EP1522855A2 Process for the identification of pesticidal agents |
| 04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522586A1 Transformed cell co-expressing cytokinin receptor and cytokinin biosynthesis enzyme |
| 04/13/2005 | EP1522585A1 Chimeric carrier molecules for the production of mucosal vaccines |
| 04/13/2005 | EP1522580A1 Crystals of an aurora-a tpx2 complex, tpx2 binding site of aurora-a, aurora-a ligands and their use |
| 04/13/2005 | EP1521968A1 Secreted polypeptide species associated with cardiovascular disorders |
| 04/13/2005 | EP1521963A2 Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521834A1 Use of a gene for increasing the oil content in plants |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521831A2 Transgenic animal expressing alzheimer's tau protein |
| 04/13/2005 | EP1521828A2 Production of polyketides |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521774A2 Truncated tau proteins |
| 04/13/2005 | EP1521773A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 04/13/2005 | EP1521772A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 04/13/2005 | EP1521771A1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 04/13/2005 | EP1521770A1 Method for the production of protamine |
| 04/13/2005 | EP1521767A2 Methods and constructs for high yield expression of clostripain |
| 04/13/2005 | EP1521766A2 SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING AND CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLING |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1521587A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 04/13/2005 | EP1478747A4 Method for making purified plasminogen activator-inhibitor type 1 (pai-1) and purified pai-1 made therefrom |
| 04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1436379A4 Dna fpr expression of alpha i-antitrypsin in methylotropic yeast |
| 04/13/2005 | EP1356075A4 Protein scaffolds for antibody mimics and other binding proteins |
| 04/13/2005 | EP1353698A4 Recombinant serum albumin for use in cleansing or dermatological products for skin or hair |
| 04/13/2005 | EP1317484B1 Variants of the phleum pratense phl p 1 allergenic protein |